Cargando…

A phosphorylation switch controls androgen biosynthesis in prostate cancer

Androgen biosynthesis enzyme 3β-hydroxysteroid dehydrogenase type 1 (3βHSD1) encoded by HSD3B1 has emerged as a potential driver for therapeutic resistance in prostate cancer. Patients with homozygous HSD3B1(1245C) inheritance are intrinsically more resistant to currently available androgen/androgen...

Descripción completa

Detalles Bibliográficos
Autor principal: Qiu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843042/
https://www.ncbi.nlm.nih.gov/pubmed/36647834
http://dx.doi.org/10.1172/JCI166499

Ejemplares similares